Terms: = Ovarian cancer AND HLF, Q16534, 3131, ENSG00000108924 AND Treatment
3 results:
1. hlf promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
[TBL] [Abstract] [Full Text] [Related]
2. Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary ovarian cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy.
Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
J Korean Med Sci; 2017 Dec; 32(12):2021-2028. PubMed ID: 29115086
[TBL] [Abstract] [Full Text] [Related]
3. treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).
Pearl ML; Dong H; Tulley S; Zhao Q; Golightly M; Zucker S; Chen WT
Gynecol Oncol; 2015 May; 137(2):229-38. PubMed ID: 25769657
[TBL] [Abstract] [Full Text] [Related]
